Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. - Wikidata - wikimedia - TriplyDB

Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study.

Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study.

http://www.wikidata.org/entity/Q34158467

about

Corticosteroids for treating sepsis Corticosteroids as adjunctive therapy in the treatment of influenza Corticosteroids for treating severe sepsis and septic shock Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008 Recently published papers: small pieces of the puzzle and the long-term view Clinical review: corticotherapy in sepsis Update on adrenal insufficiency in patients with liver cirrhosis In silico simulation of corticosteroids effect on an NFkB- dependent physicochemical model of systemic inflammation Serum macrophage migration inhibitory factor reflects adrenal function in the hypothalamo-pituitary-adrenal axis of septic patients: an observational study.Role of steroids in septic shock: assessment of knowledge, attitudes and practices among intensivists practising in Hyderabad.Transcriptome modulation by hydrocortisone in severe burn shock: ancillary analysis of a prospective randomized trial.Increased CD64 expression on polymorphonuclear neutrophils indicates infectious complications following solid organ transplantation.Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency Medicine Updating the evidence for the role of corticosteroids in severe sepsis and septic shock: a Bayesian meta-analytic perspective.Beneficial effects of stress-dose corticosteroid therapy in canines depend on the severity of staphylococcal pneumonia Role of human recombinant activated protein C and low dose corticosteroid therapy in sepsis Effects of low-dose hydrocortisone therapy on immune function in neonatal horses The Japanese guidelines for the management of sepsis.Adrenal dysfunction in portal hypertensive rats with acute hemorrhage HLA-DR expression on monocytes and systemic inflammation in patients with ruptured abdominal aortic aneurysms Differential effects of etomidate and its pyrrole analogue carboetomidate on the adrenocortical and cytokine responses to endotoxemia.Critical care medicine in AJRCCM 2003.Timing and causes of death in septic shock.Early initiation of low-dose corticosteroid therapy in the management of septic shock: a retrospective observational study.Improved diagnostic approaches to infection/sepsis detection.Dexamethasone downregulates the systemic cytokine response in patients with community-acquired pneumonia Efficacy of intraoperative, single-bolus corticosteroid administration to prevent postoperative acute respiratory failure after oesophageal cancer surgery.Management of adrenal insufficiency in different clinical settings.Methylprednisolone Protects Cardiac Pumping Mechanics from Deteriorating in Lipopolysaccharide-Treated Rats.Clinical review: a systematic review of corticosteroid use in infections.Emerging drugs for the treatment of sepsis.Treatment options for severe sepsis and septic shock.Year in review 2005: Critical Care - resource management.Corticosteroid treatment of severe community-acquired pneumonia.Stratification is the key: inflammatory biomarkers accurately direct immunomodulatory therapy in experimental sepsis.An update on the diagnosis of adrenal insufficiency and the use of corticotherapy in critical illness.Glucocorticoid receptor density and binding affinity in healthy horses and horses with systemic inflammatory response syndrome Diagnosis and treatment of adrenal insufficiency in the critically ill patient.Adrenal insufficiency in critical illness.

P2860

Q24187207-BB9A6E84-DF9E-478F-A8B4-615EB832B4BF Q24201063-161A09F5-A0F8-404C-88E4-CA4F930AD74B Q24247427-9FF012A5-E09E-4F5C-A776-10DDB34B66E8 Q24562848-C629BD93-8B5C-4A5F-892A-3D739368709C Q24644984-31389E16-C468-4EDA-95F6-9CD1E5C5228F Q24795335-8F67A9A4-1F0E-49AB-8556-0516F07C960C Q24805270-16738037-9116-4B09-BF03-CE6B2C646E93 Q27008289-E3D29B8B-5617-43D5-BB13-250D51700AFC Q28474971-F0184C43-704C-4508-A0C4-822955C33C2B Q33519766-35E33128-D175-496C-82AB-A22677705C87 Q33659548-CE28AA7E-9C9D-43A4-9F0B-A41FDF1925E1 Q33808355-AC5EB251-7FFE-4158-ADA7-FA9F67883DD6 Q33864939-2624A72F-1906-447C-B244-6FC2C4914CD6 Q33974292-20C79A4A-E8A3-4B04-9A52-320507A57FF9 Q34153235-37D370E2-59BC-463A-A38E-7F70E8699516 Q34285366-C9B3B201-BCCF-4B4E-9585-05B074F4F639 Q34469113-AE0C9625-3E34-45E3-908C-2D6D6B0F012C Q35036775-8AC2EF7E-782C-4B8A-8402-B316CF40DBA6 Q35107094-4204B772-3167-4028-9688-2D47343FD602 Q35121987-8C5ABAE7-35EA-485F-8BC1-7F9EC68F1E3F Q35544635-1648A2FA-9757-4E31-B892-5AF923A06D43 Q35624083-DF03DE41-05AD-46F4-97B8-B9DB8AB93D95 Q35626606-C014082C-D921-4917-BBE7-E836F59F3B8A Q35761868-719C22B5-929D-4D50-9704-1AB333BCC7E8 Q36093460-317269F8-9E5D-4D0F-91CD-66B29E77BDF0 Q36099375-BDEF8865-E305-4EB6-B0CE-6BF6943D565F Q36191631-A2793294-0EAC-41C7-9881-7F97CAE146E2 Q36242830-9E467848-250B-4B89-A0E6-F2164396A672 Q36301569-357F17FA-18D7-4B1B-ABB0-63F6BA604E84 Q36320106-D3C1594A-DEB5-4F68-829F-EF59A25490FD Q36342706-79D7276C-A6B6-4D2D-8BAB-CF5E8518924F Q36407391-0B7CEBEF-39A2-402F-9A8C-73BF82B3E2BE Q36505487-07238810-5CE2-4D59-AF37-9E45DB26A555 Q36526015-BB836D90-0EAB-47B4-9796-757810256F7C Q36829151-ACE71638-5FFF-4CE4-9760-12267B68E63E Q36897548-BE3A967A-43F2-468B-A3CA-5652D44C2CEF Q36910183-32CCC382-78EB-4161-BC36-00F0DC6D567B Q36975091-EF0051FA-D24D-4B37-B18E-62F93EC2038D Q36982683-62246C64-D7CB-46D6-B36B-276F0845C2A7 Q37019710-69ADAE17-035A-4BE0-89C0-9DC423725D6D

P2860

Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study.

http://www.wikidata.org/entity/Q34158467

description

2002 nî lūn-bûn

@nan

2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Immunologic and hemodynamic ef ...... o-controlled, crossover study.

@ast

Immunologic and hemodynamic ef ...... o-controlled, crossover study.

@en

Immunologic and hemodynamic ef ...... o-controlled, crossover study.

@nl

type

label

Immunologic and hemodynamic ef ...... o-controlled, crossover study.

@ast

Immunologic and hemodynamic ef ...... o-controlled, crossover study.

@en

Immunologic and hemodynamic ef ...... o-controlled, crossover study.

@nl

prefLabel

Immunologic and hemodynamic ef ...... o-controlled, crossover study.

@ast

Immunologic and hemodynamic ef ...... o-controlled, crossover study.

@en

Immunologic and hemodynamic ef ...... o-controlled, crossover study.

@nl

P1433

Q34158467-6E15D1B4-20E4-4F06-B0FA-243711008DD8

P1476

Q34158467-0DD28D70-DF2F-4BCE-B3C5-9EA71D0D611B

P2093

Q34158467-2810C605-A312-4E0B-BE33-97A8F59A7D03

Q34158467-32529E8E-C4DA-4570-AFA6-E0E23899621A

Q34158467-5A779B5A-BC10-46A6-AC15-4325383CADEC

Q34158467-5F76D4F8-FBD8-4867-B89D-56D74742FCC0

Q34158467-AC28FD77-F563-4CE3-929F-E6E4F399F34C

Q34158467-AF5BDB01-C0D1-465D-8D9B-5AB3B73AA3F1

Q34158467-CC02570A-F34A-48F3-87FC-41B7020843F9

Q34158467-DE966B4E-4E46-4549-B522-0E628B789FDA

Q34158467-F31B04E2-EC0E-402A-849B-0DD5CE1693E3

Q34158467-F9A33505-3E7A-4A5D-A9DB-BCE0829604A3

P304

Q34158467-D59F0C2B-5407-4639-95F8-067B7AA0EC9E

P31

Q34158467-E577AED2-E3FE-48A5-8F3F-9CD2162CB3C7

P356

Q34158467-0C0B307C-BAE4-4046-86AA-0D1298B1E24E

P407

Q34158467-484BBD3D-1772-46C3-A059-A3E03DEE743A

P433

Q34158467-854A0AB5-3E7E-4C6E-BE34-AA8BB5271440

P478

Q34158467-8866BFAC-E592-46C4-B444-DB23511FA7D4

P577

Q34158467-050A63CD-5131-4D23-9B70-D6CD429523C0

P698

Q34158467-D1C192D9-57FC-431C-B076-C4C3806F25A3

P921

Q34158467-2BD8C044-191B-47B8-8000-82563354CA92

Q34158467-A9A1685A-2D21-4FFB-9A9A-2368811C4653

Q34158467-FC41E97B-53D4-4DCA-AAD7-3DC395D077FF

P356

RCCM.200205-446OC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Immunologic and hemodynamic ef ...... o-controlled, crossover study.

@en

P2093

Christina Schulz

http://www.w3.org/2001/XMLSchema#string

Didier Keh

http://www.w3.org/2001/XMLSchema#string

Hans-Dieter Volk

http://www.w3.org/2001/XMLSchema#string

Herwig Gerlach

http://www.w3.org/2001/XMLSchema#string

Konrad J Falke

http://www.w3.org/2001/XMLSchema#string

Olaf Ahlers

http://www.w3.org/2001/XMLSchema#string

Steffen Weber-Cartens

http://www.w3.org/2001/XMLSchema#string

Sven Bercker

http://www.w3.org/2001/XMLSchema#string

Thomas Boehnke

http://www.w3.org/2001/XMLSchema#string

Wolf-Dietrich Doecke

http://www.w3.org/2001/XMLSchema#string

P304

512-520

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.200205-446OC

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

167

http://www.w3.org/2001/XMLSchema#string

P577

2002-11-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12426230

http://www.w3.org/2001/XMLSchema#string

P921